Buspar withdrawal
Pro Research Analysisby 
Searched over 200M research papers for "buspar withdrawal"
Buspar Withdrawal: Insights from Recent Research
Introduction to Buspar (Buspirone) and Withdrawal
Buspirone, commonly known by its brand name Buspar, is an anxiolytic medication primarily used to treat generalized anxiety disorder (GAD). Unlike benzodiazepines, buspirone does not cause significant sedation or muscle relaxation and has a lower potential for abuse and dependence 10. However, its role in managing withdrawal symptoms from various substances has been explored in several studies.
Buspirone in Opiate Withdrawal
Efficacy in Heroin and Methadone Withdrawal
Research has shown that buspirone can be effective in reducing withdrawal symptoms in individuals discontinuing heroin or methadone use. In a study involving hospitalized male chronic opiate users, buspirone significantly lowered both objective and subjective withdrawal symptoms compared to placebo 1. Another study supported these findings, indicating that buspirone, at doses of 30 mg and 45 mg, was as effective as a methadone taper in alleviating withdrawal symptoms in heroin addicts 7. Additionally, buspirone was found to improve sleep quality and reduce sleep onset latency during opioid withdrawal 4.
Mechanistic Insights
Buspirone's efficacy in opiate withdrawal is attributed to its action as a D2 antagonist and 5-HT1a agonist, which may help mitigate withdrawal symptoms by modulating serotonergic and dopaminergic pathways 47.
Buspirone in Benzodiazepine Withdrawal
Mixed Results in Benzodiazepine Withdrawal
The effectiveness of buspirone in managing benzodiazepine withdrawal symptoms has been less conclusive. A double-blind, placebo-controlled trial found that buspirone did not significantly alleviate withdrawal symptoms in chronic benzodiazepine users, and the dropout rate was higher in the buspirone group 2. Another study also concluded that buspirone did not materially assist in benzodiazepine withdrawal, although some anxiolytic effects were noted 8. However, a smaller study suggested that buspirone-treated patients tended to have lower anxiety levels than those receiving a placebo 5.
Buspirone in Nicotine Withdrawal
Ineffectiveness in Smoking Cessation
Buspirone has not shown significant benefits in managing nicotine withdrawal symptoms. A randomized, placebo-controlled trial involving heavy smokers found no significant effect of buspirone on nicotine withdrawal symptoms or relapse rates 3. Both buspirone and placebo groups experienced significant withdrawal effects, and buspirone did not offer additional relief.
Buspirone in Alcohol Withdrawal
Preliminary Findings
Preliminary investigations into the use of buspirone for alcohol withdrawal have shown promising results. In a study with 118 patients undergoing alcohol detoxification, buspirone effectively controlled withdrawal symptoms without causing significant side effects 6. This suggests a potential role for buspirone in alcohol withdrawal management, although further research is needed.
Conclusion
Buspirone has demonstrated efficacy in managing withdrawal symptoms from opiates, particularly heroin and methadone, by reducing both objective and subjective symptoms and improving sleep quality. However, its effectiveness in benzodiazepine and nicotine withdrawal is less clear, with mixed results and limited benefits observed. Preliminary findings suggest a potential role for buspirone in alcohol withdrawal, but more research is required to confirm these results. Overall, buspirone's unique pharmacological profile makes it a valuable option in certain withdrawal scenarios, particularly for opiate dependence.
Sources and full results
Most relevant research papers on this topic
Effects of buspirone in withdrawal from opiates.
Buspirone effectively reduces objective and subjective withdrawal symptoms in heroin addicts and methadone-maintained patients after cessation of opiate use.
RCTA Double-Blind Placebo-Controlled Study of Buspirone in Diazepam Withdrawal in Chronic Benzodiazepine Users
Buspirone does not appear to help alleviate benzodiazepine withdrawal symptoms and may increase dropout rates in chronic benzodiazepine users.
RCTBuspirone Effect On Tobacco Withdrawal Symptoms: A Randomized Placebo-Controlled Trial
Buspirone provided no relief from nicotine withdrawal symptoms in heavy smokers, and relapsed smokers experienced more intense withdrawal regardless of treatment.
RCTA double-blind, randomized, placebo-controlled, pilot clinical trial examining buspirone as an adjunctive medication during buprenorphine-assisted supervised opioid withdrawal.
Buspirone can help mitigate opioid withdrawal during supervised opioid taper, potentially benefiting protracted withdrawal periods.
RCTBuspirone treatment as an aid to benzodiazepine withdrawal
Buspirone treatment may help reduce anxiety levels during benzodiazepine withdrawal, but both groups successfully completed withdrawal.
RCTThe role of buspirone in the management of alcohol withdrawal: a preliminary investigation.
Buspirone HCl effectively controls alcohol withdrawal symptoms and may play a role in detoxification as a non-traditional medication.
Efficacy of Buspirone in the Treatment of Opioid Withdrawal
Buspirone, at doses of 30 and 45 mg, is as effective as a methadone taper in alleviating heroin withdrawal symptoms, making it a potential outpatient treatment option.
RCTA Comparison of Buspirone and Placebo in Relieving Benzodiazepine Withdrawal Symptoms
Buspirone does not help benzodiazepine withdrawal and does not suppress benzodiazepine withdrawal symptoms.
RCT
Highly CitediPhone® applications as versatile video tracking tools to analyze behavior in zebrafish (Danio rerio)
This study developed a cost-effective video tracking system using Apple® applications to measure behavioral changes in zebrafish after chronic ethanol exposure and drug treatments.
Non-RCT
Animal StudyBuspirone: An Update on a Unique Anxiolytic Agent
Buspirone is a promising anxiolytic agent for treating generalized anxiety disorders, with comparable efficacy to benzodiazepines and low frequency of adverse effects.
Highly Cited